Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Makes Clinical Research Comeback But Challenges Remain

This article was originally published in PharmAsia News

Executive Summary

Recent steps by the Indian government to streamline procedures for clinical trials are bringing a new glimmer of hope to the beleaguered industry. An improved framework now exists that puts India in a better place than pre-2010, however it may take more collaborative efforts to align India with international norms, says Gopalkrishna Pai, General Manager, George Clinical (India).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts